Persistent ocular surface dysfunction after cataract surgery impacts patient satisfaction despite 20/20 vision, with pre-op screening and tailored care being key components.

Milton Hom, OD, FAAO, took a deep dive into the lipid, aqueous, and mucin tear film layers to determine specialized treatment options for different types of dry eye.

Creating a healthier population will require extended efforts by optometrists.

Catch up on the top stories in optometry during the week of February 24-February 28.

The gel was investigated in a case series, which was presented in a poster at SECO 2025.

Julie Rodman, OD, MS, FAAO, sits down with Optometry Times to discuss her anticipation for the future of technology in optometry, especially retinal care.

HB 1352 will take effect in August 2025 with additional provisions to roll out based on plan renewals, contract changes, or by January 1, 2026.

The company also reported a positive outcome of an analysis of masked data from its ongoing MAGNIFY Phase 2 trial for zervimesine in adults with GA.

Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.

Discovery may lead to new treatment options for dry eye disease.

Updates include enrollments for LYNX-2 pivotal Phase 3 and VEGA-3 pivotal Phase 3 trials, in addition to a US FDA Fast Track Designation granted for phentolamine 0.75% for the treatment of significant chronic night driving impairment in keratorefractive patients with reduced mesopic vision.

Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.

Wearable technology options can meet patient’s goals.

Ahead of her SECO presentations, Julie Rodman, OD, MS, FAAO, shares some tidbits of what attendees can expect.

The study examined changes in genes and proteins of the retinas of 9 strains of mice.

Alysse Henkel, vice president of Research and inSights at The Vision Council, advised that expanding budget and mid-market frame options may help improve frames sales.

Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.